Escalating Monthly Doses of Tafenoquine in Healthy Volunteers
NCT05203744
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
FED
Sponsor class
Conditions
Prophylaxis
Interventions
DRUG:
Tafenoquine prophylaxis
Sponsor
Naval Medical Research Center
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]